SPDR S&P Biotech ETF Stock Forecast, Price & News

Wall Street analysts have given SPDR S&P Biotech ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SPDR S&P Biotech ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XBI shares have increased by 56.2% and is now trading at $123.41.
View which stocks have been most impacted by COVID-19.

SPDR S&P Biotech ETF pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.24%.
View SPDR S&P Biotech ETF's dividend history.

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Nasdaq Biotechnology ETF (IBB), The Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

SPDR S&P Biotech ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Cutler Group LP (0.00%), Cumberland Advisors Inc. (0.45%), Carnegie Capital Asset Management LLC (0.19%), Whittier Trust Co. of Nevada Inc. (0.19%), Aurora Investment Managers LLC. (0.14%) and CMH Wealth Management LLC (0.12%).

XBI stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP, NEXT Financial Group Inc, Ayalon Holdings Ltd., RFG Holdings Inc., XR Securities LLC, Great Valley Advisor Group Inc., Hanson & Doremus Investment Management, and Greenwich Wealth Management LLC.

XBI stock was purchased by a variety of institutional investors in the last quarter, including Cumberland Advisors Inc., Aurora Investment Managers LLC., Carnegie Capital Asset Management LLC, Apella Capital LLC, Marotta Asset Management, CMH Wealth Management LLC, RWM Asset Management LLC, and Usca Ria LLC.

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XBI stock can currently be purchased for approximately $123.41.

SPDR S&P Biotech ETF has a market capitalization of $6.73 billion.

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

SPDR S&P Biotech ETF is headquartered at One Lincoln Street, Boston, 02111, United States.

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.